You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 16 No. 5, May 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Maple Syrup Disease

Effects of Dietary Therapy on Cerebral Lipids

John H. Menkes, MD; H. Solcher, MD

Arch Neurol. 1967;16(5):486-491.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MAPLE syrup disease is a rapidly progressive familial cerebral degenerative condition marked by the excretion of a urine possessing a sweet, maple syrup-like odor.1 The enzymatic basis for this disease is a failure in the oxidative decarboxylation of three branched-chain keto acids, the derivatives of leucine, valine, and isoleucine. As a consequence of the defect, these compounds and their amino acid analogues are excreted in large amounts, and plasma levels of branched-chain amino acids are many times higher than normal.2 Hypertonia, disturbances in respiration, and seizures appear shortly after birth and prove to be fatal within a few weeks or months in a majority of children.

In analogy to the therapy for phenylketonuria, Holt et al first suggested regulating the abnormal blood levels of branchedchain amino acids by means of a completely synthetic diet in which the intake of leucine, isoleucine, valine, and methionine could be carefully . . . [Full Text PDF of this Article]


Author Affiliations

Baltimore; Marburg, Germany

From the Department of Pediatrics, Johns Hopkins Hospital, Baltimore (Dr. Menkes); and the Psychiatric and Neurologic Clinic, University of Marburg an der Lahn, Marburg, Germany (Dr. Solcher). Mr. Menkes' present address is the Division of Pediatric Neurology, UCLA School of Medicine, Los Angeles.


Footnotes

Submitted for publication Oct 24, 1966; accepted Dec 9.

Reprint requests to Division of Pediatric Neurology, UCLA School of Medicine, Los Angeles 90024 (Dr. Menkes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.